Double-Blind, Placebo-Controll ed, Single Ascending-Dose Study in Healthy Subjects With PRX002, an Anti-α-Synucl ein Monoclonal Antibody

4 (40.0) 4 (66.7) 1 (16.7) 1 (16.7) 2 (33.3) 2 (33.3) Asian 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (16.7) 0 (0.0) 1 (16.7) 0 (0.0) 0 (0.0)